+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Discovery Informatics - Global Strategic Business Report

  • PDF Icon

    Report

  • 188 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804178
Description Jump to:
The global market for Drug Discovery Informatics is estimated at US$2.5 Billion in 2023 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Drug Discovery Informatics Software segment, which is expected to reach US$3 Billion by 2030 with a CAGR of 7.9%. The Drug Discovery Informatics Services segment is also set to grow at 9.5% CAGR over the next 8 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $744.5 Million in 2023, and China, forecasted to grow at an impressive 7.9% CAGR to reach $824.6 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Drug Discovery Informatics Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Drug Discovery Informatics Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Drug Discovery Informatics Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Certara USA, Inc., Charles River Laboratories International, Inc., Collaborative Drug Discovery, Inc., and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 29 Featured):

  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Drug Discovery Informatics: A Prelude
  • Drug Discovery Informatics - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market
  • Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019
  • Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market
  • Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics
  • Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics
  • The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine
  • Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Cloud Computing Emerges to Play a Key Role in Bioinformatics
  • Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics
  • Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024
  • Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics
  • Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025
  • Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics
  • Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics
  • Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World 7-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 22: World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 25: World Drug Discovery Informatics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 26: World Recent Past, Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 27: World 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Drug Discovery Informatics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedApril 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.8 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal

Related Topics

Related Reports

Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Drug Discovery Informatics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Global Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Forecast 2024-2030 - Product Image

Global Drug Discovery Informatics Market by Solutions (Services, Software), Functions (Docking, Libraries & Database Preparation, Molecular Modeling), End-User, Application - Forecast 2024-2030

  • Report
  • 189 Pages
  • Global
From
Drug Discovery Informatics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow, Service, Solution, End User, and Geography - Product Image

Drug Discovery Informatics Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Workflow, Service, Solution, End User, and Geography

  • Report
  • 150 Pages
  • Global
From
Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Regional Outlook and Forecast, 2024 - 2031 - Product Image

Global Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Application (Drug Discovery, and Drug Development), By Function, By End User, By Regional Outlook and Forecast, 2024 - 2031

  • Report
  • 264 Pages
  • Global
From
Drug Discovery Informatics Global Market Report 2024 - Product Image

Drug Discovery Informatics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.